• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Catalog Number UNK CDS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Inflammation (1932); Renal Failure (2041)
Event Date 01/01/2008
Event Type  Injury  
Event Description
This is filed to report that in a systematic review and meta-analysis study, where patients had undergone a mitraclip procedure, hypotension, acute kidney injury, and inflammation was reported.Although hypotension is not reportable, acute kidney injury and inflammation are considered serious injuries.This article is a systematic review and meta-analysis of the prognostic impact of pre- and post- procedural renal dysfunction on late all-cause mortality outcome following transcatheter edge-to-edge repair (teer) of the mitral valve using mitraclip (mc).The goal of this meta-analysis was to evaluate the impact of pre- and post- procedural renal dysfunction on late (=12 months) all-cause mortality following teer with mc.Electronic databases were systematically reviewed for studies evaluating mc outcome.Out of 2606 articles, 15 studies with 19,545 patients were included.Complications included late all-cause mortality.Pre-procedural renal dysfunction i.E. chronic kidney disease (ckd) was independently associated with higher late all-cause mortality.In addition, the development of post-procedural renal dysfunction was independently associated with higher late all-cause mortality after teer with mc.Pre- and post-procedural renal dysfunction is a strong independent predictor of late all-cause mortality following teer with mc and this should be considered during periprocedural planning for these patients.Specific patient information is documented as unknown.Details are listed in the attached article, titled, prognostic impact of pre- and post- procedural renal dysfunction on late all-cause mortality outcome following transcatheter edge-to-edge repair of the mitral valve: a systematic review and meta-analysis.No additional information was provided.
 
Manufacturer Narrative
The devices are not returning for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Dates estimated.The udi number is ¿ni¿ as the catalog number was not provided.The additional patient effect(s) reported in the article are captured under a separate medwatch report.Attached article, titled, prognostic impact of pre- and post- procedural renal dysfunction on late all-cause mortality outcome following transcatheter edge-to-edge repair of the mitral valve: a systematic review and meta-analysis.
 
Manufacturer Narrative
The device was not returned for analysis.The lot history record (lhr) review was not performed because no lot information was provided.Based on available information, the reported hypotension appears to be related to procedural circumstances.The reported renal failure appears to be a secondary effect of the hypotension and inflammatory response.The reported inflammation was likely due to procedural circumstances.The reported patient effects of renal failure, hypotension, hypersensitivity reaction (inflammatory response), as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported serious injury/ illness/ impairment was associated with no known treatment provided to the reported patient effects.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14337905
MDR Text Key291223021
Report Number2024168-2022-05017
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK CDS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/18/2022
Initial Date FDA Received05/09/2022
Supplement Dates Manufacturer Received07/01/2022
Supplement Dates FDA Received07/07/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age75 YR
Patient SexMale
-
-